Development of indole-3-propionic acid (OXIGON™) for Alzheimer's disease

被引:140
作者
Bendheim, PE [1 ]
Poeggeler, B
Neria, E
Ziv, V
Pappolla, MA
Chain, DG
机构
[1] Mindset Biopharmaceut Ltd, Jerusalem, Israel
[2] Univ Gottingen, D-3400 Gottingen, Germany
[3] Univ S Alabama, Mobile, AL 36688 USA
关键词
Alzheimer's disease; beta-amyloid; oxidative stress; indole-3-propionic acid;
D O I
10.1007/s12031-002-0036-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The accumulation of amyloid-beta and concomitant oxidative stress are major pathogenic events in Alzheimer's disease. Indole-3-propionic acid (IPA, OXIGON(TM)) is a potent anti-oxidant devoid of pro-oxidant activity. IPA has been demonstrated to be an inhibitor of beta-amyloid fibril formation and to be a potent neuroprotectant against a variety of oxidotoxins. This review will summarize the known properties of IPA and outline the rationale behind its selection as a potential disease-modifying therapy for Alzheimer's disease.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 32 条
[1]   OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[2]   Mechanisms of DNA oxidation [J].
Aust, AE ;
Eveleigh, JF .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :246-252
[3]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[4]   VITAMIN-E PROTECTS NERVE-CELLS FROM AMYLOID BETA-PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, J ;
COLE, GM ;
SCHUBERT, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) :944-950
[5]   Potent neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid [J].
Chyan, YJ ;
Poeggeler, B ;
Omar, RA ;
Chain, DG ;
Frangione, B ;
Ghiso, J ;
Pappolla, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (31) :21937-21942
[6]   Antioxidant therapy in neurologic disease [J].
Delanty, N ;
Dichter, MA .
ARCHIVES OF NEUROLOGY, 2000, 57 (09) :1265-1270
[7]   Antioxidants, oxidative stress, and degenerative neurological disorders [J].
Floyd, RA .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :236-245
[8]   SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein [J].
Iadecola, C ;
Zhang, FY ;
Niwa, K ;
Eckman, C ;
Turner, SK ;
Fischer, E ;
Younkin, S ;
Borchelt, DR ;
Hsiao, KK ;
Carlson, GA .
NATURE NEUROSCIENCE, 1999, 2 (02) :157-161
[9]   Carcinogen-induced, free radical-mediated reduction in microsomal membrane fluidity: Reversal by indole-3-propionic acid [J].
Karbownik, M ;
Garcia, JJ ;
Lewinski, A ;
Reiter, RJ .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2001, 33 (01) :73-78
[10]   Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in hamster testes [J].
Karbownik, M ;
Gitto, E ;
Lewiñski, A ;
Reiter, RJ .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2001, 81 (04) :693-699